Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody‐mediated arthritis in a murine model
- 29 June 2010
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (7) , 1921-1932
- https://doi.org/10.1002/art.27470
Abstract
Chemokines coordinate leukocyte trafficking in homeostasis and during immune responses. Prior studies of their role in arthritis have used animal models with both an initial adaptive immune response and an inflammatory effector phase. We undertook analysis of chemokines and their receptors in the effector phase of arthritis using the K/BxN mouse serum-transfer model. A time-course microarray analysis of serum-transferred arthritis was performed, examining ankle tissue, synovial fluid, and peripheral blood leukocytes. Up-regulation of chemokines was confirmed by quantitative reverse transcriptase-polymerase chain reaction. The functional relevance of chemokine induction was assessed by transferring serum into mice deficient in CCR1-7, CCR9, CXCR2, CXCR3, CXCR5, CX(3)CR1, CCL2, or CCL3. Further mechanistic analysis of CXCR2 involved treatment of arthritic mice with a CXCR2 antagonist, bone marrow (BM) cell transfers with CXCR2(+/-) and CXCR2(-/-) donors and recipients, flow cytometry of synovial cells, and competition experiments measuring enrichment of CXCR2-expressing neutrophils in arthritic joints of mice with mixed CXCR2(+/+) and CXCR2(-/-) BM cells. Gene expression profiling revealed up-regulation of the CXCR2 ligands CXCL1, CXCL2, and CXCL5 in the joint in parallel with disease activity. CXCR2(-/-) mice had attenuated disease relative to CXCR2(+/-) littermates, as did mice receiving the CXCR2 inhibitor, while deficiency of other chemokine receptors did not affect arthritis severity. CXCR2 was required only on hematopoietic cells and was widely expressed on synovial neutrophils. CXCR2-expressing neutrophils were preferentially recruited to arthritic joints in the presence of CXCR2-deficient neutrophils. CXCR2 (but not other chemokine receptors) is critical for the development of autoantibody-mediated arthritis, exhibiting a cell-autonomous role in neutrophil recruitment to inflamed joints.Keywords
This publication has 50 references indexed in Scilit:
- The chemokine receptors CXCR1/CXCR2 modulate antigen‐induced arthritis by regulating adhesion of neutrophils to the synovial microvasculatureArthritis & Rheumatism, 2008
- The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune diseaseThe Journal of Experimental Medicine, 2008
- Blockade of the chemokine receptor CXCR2 ameliorates adjuvant‐induced arthritis in ratsBritish Journal of Pharmacology, 2008
- Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitorsProceedings of the National Academy of Sciences, 2007
- Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1Proceedings of the National Academy of Sciences, 2007
- Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networksin vivoBritish Journal of Pharmacology, 2006
- A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritisThe Journal of Experimental Medicine, 2006
- CXCL13 neutralization reduces the severity of collagen‐induced arthritisArthritis & Rheumatism, 2005
- Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout MiceCirculation, 2003